Selected article for: "activation state and acute respiratory"

Author: Guillet, Henri; Gallet, Romain; Pham, Vincent; D’Humières, Thomas; Huguet, Raphaelle; Lim, Pascal; Michel, Marc; Khellaf, Mehdi
Title: Clinical spectrum of ischaemic arterial diseases associated with COVID-19: a series of four illustrative cases
  • Cord-id: eylykp74
  • Document date: 2020_12_25
  • ID: eylykp74
    Snippet: BACKGROUND: Severe coronavirus-induced disease 2019 (COVID-19) leads to acute respiratory distress syndrome with an increased risk of venous thrombo-embolic events. To a much lesser extent, arterial thrombo-embolic events have also been reported in this setting. CASE SUMMARY: Here, we describe four different cases of COVID-19 infection with ischaemic arterial events, such as a myocardial infarction with high thrombus load, ischaemic stroke on spontaneous thrombosis of the aortic valve, floating
    Document: BACKGROUND: Severe coronavirus-induced disease 2019 (COVID-19) leads to acute respiratory distress syndrome with an increased risk of venous thrombo-embolic events. To a much lesser extent, arterial thrombo-embolic events have also been reported in this setting. CASE SUMMARY: Here, we describe four different cases of COVID-19 infection with ischaemic arterial events, such as a myocardial infarction with high thrombus load, ischaemic stroke on spontaneous thrombosis of the aortic valve, floating thrombus with mesenteric, splenic and renal infarction, and acute limb ischaemia. DISCUSSION: Cardiovascular risk factors such as hypertension, obesity, and diabetes are comorbidities most frequently found in patients with a severe COVID-19 infection and are associated with a higher death rate. Our goal is to provide an overview of the clinical spectrum of ischaemic arterial events that may either reveal or complicate COVID-19. Several suspected pathophysiological mechanisms could explain the association between cardiovascular events and COVID-19 (role of systemic inflammatory response syndrome, endothelial dysfunction, activation of coagulation cascade leading to a hypercoagulability state, virus-induced secondary antiphospholipid syndrome). We need additional studies of larger size, to estimate the incidence of these arterial events and to assess the efficacy of anticoagulation therapy.

    Search related documents:
    Co phrase search for related documents
    • abdominal aorta and acute ischaemia: 1, 2
    • abdominal aorta and acute occlusion: 1, 2, 3
    • abdominal aorta and acute respiratory distress syndrome: 1
    • abdominal aorta and lmwh molecular weight heparin: 1
    • acl igg anti negative and lmwh molecular weight heparin: 1
    • active treatment and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • active treatment and acute respiratory failure: 1, 2, 3, 4, 5
    • active treatment and additional study: 1, 2, 3
    • active treatment and lmwh molecular weight heparin: 1
    • acute occlusion and lmwh molecular weight heparin: 1
    • acute respiratory distress syndrome and additional study: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory distress syndrome and lmwh molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute respiratory distress syndrome and lmwh prophylactic dose: 1
    • acute respiratory failure and additional study: 1, 2, 3
    • acute respiratory failure and lmwh molecular weight heparin: 1, 2, 3, 4